Evidence map›Paper›PMID 36873595›Full record

ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2022

Demographics and Clinical Characteristics of COVID-19-vaccinated Patients Admitted to ICU: A Multicenter Cohort Study from India (PostCoVac Study-COVID Group).

Amarja Ashok Havaldar, Jay Prakash, Sanjeev Kumar, Kaladhar Sheshala, Abhilash Chennabasappa, Ria Rachel Thomas, Ea Chinny Sushmitha, Mohd Saif Khan, Raman Kumar, Srishti Kindo and 6 more

Abstract read
In one paragraph

Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Amarja Ashok HavaldarDepartment of Critical Care Medicine, St John's Medical College Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-8763-3585
Jay PrakashDepartment of Critical Care Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-5290-3848
Sanjeev KumarDepartment of Anaesthesiology and Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.ORCID https://orcid.org/0000-0001-5055-9126
Kaladhar SheshalaDepartment of Critical Care Medicine, Yashoda Hospitals, Hyderabad, Telangana, India.ORCID https://orcid.org/0000-0002-1399-0387
Abhilash ChennabasappaDepartment of Anaesthesia and Critical Care, JSS Hospital, Mysuru, Karnataka, India.ORCID https://orcid.org/0000-0003-1858-1600
Ria Rachel ThomasDepartment of Critical Care Medicine, St John's Medical College Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0003-3882-9650
Ea Chinny SushmithaDepartment of Critical Care Medicine, St John's Medical College Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0001-5141-9010
Mohd Saif KhanDepartment of Critical Care Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-9430-0076
Raman KumarDepartment of Anaesthesiology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-1220-4137
Srishti KindoDepartment of Anaesthesiology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-4694-0458
Ritu SinghDepartment of Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.ORCID https://orcid.org/0000-0001-9855-456X
Munta KartikDepartment of Critical Care Medicine, Yashoda Hospitals, Hyderabad, Telangana, India.ORCID https://orcid.org/0000-0001-6253-5252
Akshay Hiruyur Manjunatha SwamyDepartment of Anaesthesia and Critical Care, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.ORCID https://orcid.org/0000-0001-5915-6841
John Michael RajDepartment of Biostatistics, St John's Medical College Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-1526-7432
Tinku ThomasDepartment of Biostatistics, St John's Medical College Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-1786-6076
Sumithra SelvamDivision of Epidemiology and Biostatistics, St John's Research Institute, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0003-3229-267X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emergency authorization and approval were given for the coronavirus disease-19 (COVID-19) vaccines. The efficacy reported after phase III trials were 70.4% and 78% for Covishield and Covaxin, respectively.In this study, we aim to analyze the risk factors, which were associated with mortality in critically ill COVID-19-vaccinated patients admitted into intensive care unit (ICU). Materials and methods: This study was conducted from April 1, 2021 to December 31, 2021 across five centers in India. Patients who had received either one or two doses of any of the COVID vaccines and developed COVID-19 were included. The ICU mortality was a primary outcome. Results: A total of 174 patients with COVID-19 illness were included in the study. The mean age was 57 years standard deviation (SD 15). Acute physiology, age and chronic health evaluation (APACHE II) score and the sequential organ failure assessment (SOFA) score were 14 (8-24.5) and 6 (4-8), respectively. Multiple variable logistic regression showed patients who have received a single dose [odds ratio (OR): 2.89, confidence interval (CI): 1.18, 7.08], neutrophil:lymphocyte (NL) ratio (OR: 1.07, CI: 1.02,1.11), and SOFA score (OR: 1.18, CI: 1.03,1.36) were associated with higher mortality. Conclusion: The mortality in the vaccinated patients admitted to the ICU was 43.68% due to COVID illness. The mortality was lower in patients who had received two doses. How to cite this article: Havaldar AA, Prakash J, Kumar S, Sheshala K, Chennabasappa A, Thomas RR et al

Indexed as

BBV152Breakthrough infectionChAdOx1 nCOV19CovaxinCOVID-19COVID vaccinationDelta variantICUMulticenter study

Identifiers

PMID36873595
PMCPMC9983652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.